Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Sells $226,697.56 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 14,692 shares of the stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $15.43, for a total transaction of $226,697.56. Following the completion of the sale, the chief financial officer now directly owns 1,402,862 shares in the company, valued at approximately $21,646,160.66. The trade was a 1.04 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Robert Thomas Freeman also recently made the following trade(s):

• On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total transaction of $3,390,121.35.
• On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.58, for a total transaction of $3,895,000.00.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC opened at $15.79 on Friday. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The company has a market capitalization of $3.03 billion, a price-to-earnings ratio of -20.51 and a beta of 1.49. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $16.25. The business has a 50 day simple moving average of $14.38 and a 200-day simple moving average of $12.43.

Institutional Trading of Alignment Healthcare

Several institutional investors have recently added to or reduced their stakes in ALHC. Principal Financial Group Inc. grew its position in shares of Alignment Healthcare by 1,335.1% during the 3rd quarter. Principal Financial Group Inc. now owns 194,043 shares of the company’s stock valued at $2,294,000 after buying an additional 180,522 shares during the last quarter. Royce & Associates LP bought a new position in shares of Alignment Healthcare during the third quarter valued at approximately $3,782,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Alignment Healthcare during the third quarter valued at approximately $131,000. Intech Investment Management LLC acquired a new stake in shares of Alignment Healthcare during the 3rd quarter worth approximately $315,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Alignment Healthcare by 1.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 839,695 shares of the company’s stock worth $9,925,000 after purchasing an additional 13,865 shares during the last quarter. Institutional investors own 86.19% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on ALHC. Piper Sandler increased their target price on Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, March 4th. Stifel Nicolaus lifted their price objective on Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. William Blair restated an “outperform” rating on shares of Alignment Healthcare in a report on Friday, February 28th. Barclays raised their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a research report on Friday, February 28th. Finally, Bank of America upped their price objective on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a research note on Tuesday, March 4th. One analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $14.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.